Suppr超能文献

氩离子凝固术与内镜切除术治疗胃腺瘤的系统评价与Meta分析

Argon plasma coagulation versus endoscopic resection for the treatment of gastric adenomas: A systematic review and meta-analysis.

作者信息

Lee Jae Gon, Park Jin Hwa, Lee Sang Pyo, Lee Kang Nyeong

机构信息

Department of Internal Medicine, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Korea.

Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea.

出版信息

Saudi J Gastroenterol. 2025 May 1;31(3):137-145. doi: 10.4103/sjg.sjg_418_24. Epub 2025 Apr 18.

Abstract

BACKGROUND

Endoscopic resection (ER) is regarded as the treatment of choice for gastric adenoma. Argon plasma coagulation (APC) is also widely used, but its efficacy and safety have not been fully established. We performed a systematic review and meta-analysis to assess the efficacy and safety of APC compared with ER in treating gastric adenoma.

METHODS

PubMed, EMBASE, and the Cochrane Library were searched up to April 2024. All studies that evaluated the clinical outcomes of APC or ER for treating gastric adenomas were included. The primary outcome was the local recurrence rates of APC versus ER. Secondary outcomes included procedure time, length of hospital stay, and complications.

RESULTS

A total of seven studies were included, of which four were retrospective studies that compared the outcomes of APC and ER, and three were retrospective single-arm studies that reported only outcomes of APC. APC was associated with a higher local recurrence rate in treating gastric adenoma than ER [risk ratio (RR) 4.378, 95% CI 1.995-9.607] but involved shorter procedure times (MD -45.228, 95% CI -49.436 to -41.021), shorter hospital stays (MD -2.684, 95% CI -2.932 to -2.437), and fewer complications (RR 0.329, 95% CI 0.124-0.869).

CONCLUSIONS

APC results in more local recurrence but involved a lower risk of complications than ER. APC may be considered an alternative to ER in treating gastric adenomas.

摘要

背景

内镜下切除术(ER)被视为胃腺瘤的首选治疗方法。氩离子凝固术(APC)也被广泛应用,但其疗效和安全性尚未完全确立。我们进行了一项系统评价和荟萃分析,以评估APC与ER治疗胃腺瘤的疗效和安全性。

方法

检索截至2024年4月的PubMed、EMBASE和Cochrane图书馆。纳入所有评估APC或ER治疗胃腺瘤临床结局的研究。主要结局是APC与ER的局部复发率。次要结局包括手术时间、住院时间和并发症。

结果

共纳入7项研究,其中4项为比较APC和ER结局的回顾性研究,3项为仅报告APC结局的回顾性单臂研究。APC治疗胃腺瘤的局部复发率高于ER[风险比(RR)4.378,95%置信区间1.995 - 9.607],但手术时间较短(平均差 - 45.228,95%置信区间 - 49.436至 - 41.021),住院时间较短(平均差 - 2.684,95%置信区间 - 2.932至 - 2.437),并发症较少(RR 0.329,95%置信区间0.124 - 0.869)。

结论

APC导致更多的局部复发,但与ER相比并发症风险较低。在治疗胃腺瘤时,APC可被视为ER的替代方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac6d/12155460/a04866950b85/SJG-31-137-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验